Source comparison
TB-500 Studied Joint Pain: Research vs Clinical Comparison
Rat OA model (monoiodoacetate-induced) Cartilage thickness via histology, inflammatory cytokine levels 1mg/kg twice weekly subcutaneous 4 weeks High (controlled, blinded, multiple replications) Consistently shows structural cartilage preservation and reduced I
This comparison does not assign a generated winner or score.
- Rat OA model (monoiodoacetate-induced)
- Cartilage thickness via histology, inflammatory cytokine levels
- 1mg/kg twice weekly subcutaneous
- 4 weeks
- High (controlled, blinded, multiple replications)
- Consistently shows structural cartilage preservation and reduced IL-1β, TNF-α
- Equine naturally occurring OA
- Lameness scoring, synovial fluid analysis
- 7.5mg twice weekly intramuscular
- 6 weeks
- Moderate (observational, veterinary records)
- Demonstrates functional improvement with biomarker correlation
- Human Achilles tendinopathy pilot
- VISA-A pain/function questionnaire
- 2mg twice weekly subcutaneous
- 8–12 weeks
- Low-moderate (no true placebo arm, small n=42)
- Shows clinically meaningful improvement but lacks robust control
- Rabbit tendon repair surgical model
- Tensile strength testing, collagen alignment
- 0.5mg/kg three times weekly
- 3 weeks
- High (controlled, mechanical testing)
- Accelerates structural healing but joint pain not primary endpoint